UNIPHYLLIN CONTINUS Prolonged release tablet Ref.[7752] Active ingredients: Theophylline

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2023  Publisher: Ennogen Healthcare Ltd, Unit G4, Riverside Industrial Estate, Riverside Way, Dartford, DA1 5BS, UK

Product name and form

UNIPHYLLIN CONTINUS 200mg prolonged release tablets.

Pharmaceutical Form

Prolonged release tablet.

White, capsule shaped tablet, plain on one side and marked ‘U200’ on the other.

Qualitative and quantitative composition

Each prolonged-release tablet contains 200 mg theophylline as 220 mg theophylline monohydrate.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Theophylline

Theophylline is a bronchodilator. In addition it affects the function of a number of cells involved in the inflammatory processes associated with asthma and chronic obstructive airways disease. Theophylline stimulates the myocardium and produces a diminution of venous pressure in congestive heart failure leading to marked increase in cardiac output.

List of Excipients

Hydroxyethylcellulose
Povidone (K25)
Cetostearyl alcohol
Macrogol 6000
Talc
Magnesium stearate

Pack sizes and marketing

Blister packs consisting of aluminium foil sealed to 250 ยต m PVC with a PVdC coating of at least 40 gsm thickness, containing 8 or 56 tablets.

Polypropylene containers containing 60, 100, 250 or 1000 tablets.

Amber glass bottles containing 50 or 100 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder

Ennogen Healthcare Ltd, Unit G4, Riverside Industrial Estate, Riverside Way, Dartford, DA1 5BS, UK

Marketing authorization dates and numbers

PL 40739/0328

23 August 1979 / 15 May 2003

Drugs

Drug Countries
UNIPHYLLIN Cyprus, Ireland, Malta, United Kingdom

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.